Sepiapterin

ATC A16AX28 · 5 markets · 12 records

Sepiapterin 5 markets · 12 records Forms

US 4 records · 2 strengths

1,000 mgpowderSephience also in AU·CA
250 mgpowderSephience also in AU·CA

AU 3 records · 3 strengths

1,000 mgpowderSEPHIENCE sepiapterin 1000 mg oral powder sachet also in US·CA unknown
250 mgpowderSEPHIENCE sepiapterin 1000 mg oral powder sachet also in US·CA unknown

Records without a stated strength · 1 Sephience

CA 2 records · 2 strengths

1,000 mgpowderSephience also in US·AU
250 mgpowderSephience also in US·AU

EU 1 records · 1 strengths

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Records without a stated strength · 1 Sephience

Side-by-side table

Strength / form / release	US	CA	AU	EU
1,000 mg powder	Sephience	Sephience	SEPHIENCE sepiapterin 1000 mg oral powder sachet	not recorded
250 mg powder	Sephience	Sephience	SEPHIENCE sepiapterin 1000 mg oral powder sachet	not recorded
not disclosed unknown	not recorded	not recorded	Sephience	Sephience

Scroll horizontally for more markets →

Each country column shows the locally registered trade names — not translations.

“not disclosed” means the source does not publish the strength — it does not mean the product has none.

Australia ARTG data has no registration-status column, so status is shown as unknown; being on the register does not mean currently marketed.

EU centralised authorisation (EMA) — Authorised at EU level — not a record of sale in any single country. The EU register carries no strength, dosage form or pack size.

Back to the list

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.